We are pleased to announce that 15 more titles from BioMed Central’s portfolio of journals have recently been accepted for Impact Factor tracking by Thomson Reuters and should receive their first Impact Factors in June 2013.
The acceptance of these titles for tracking reflects their growing prominence and reputation in their respective fields. This is a strong endorsement of their achievement to date and the quality of the content they publish:
- AIDS Research and Therapy
- Alzheimer’s Research & Therapy
- Annals of Clinical Microbiology and Antimicrobials
- Annals of General Psychiatry
- BMC Anesthesiology
- BMC Geriatrics
- BMC Oral Health
- BMC Pulmonary Medicine
- BMC Urology
- BMC Women’s Health
- Genome Medicine
- Head & Face Medicine
- Journal of Occupational Medicine and Toxicology
- Reproductive Health
- World Journal of Emergency Surgery.
In addition, the following journals already in Science Citation Index Expanded have now been ‘promoted’ by Thomson Reuters and from 2013 will be part of Science Citation Index: BMC Biology, BMC Medical Ethics, BMC Veterinary Research, Implementation Science and Particle Fibre Toxicology.
We would like to congratulate the Editors-in-Chief of all the newly tracked journals on their impressive achievement.
BioMed Central’s growing journal portfolio consists of more than 240 titles which span all areas of biology and medicine. Over 130 of these journals are already tracked by Thomson Reuters and, in total, 22 additional BioMed Central journals are expected to receive first Impact Factors in June 2013.
We look forward to seeing many more journals being accepted for tracking in the near future.
Find out more about publishing in a BioMed Central journal here.